COPA and autoimmune interstitial lung disease-arthritis syndrome: This approach was based on the assumption that the reduced target protein binding efficiency of loss of function mutations identified in COPA syndrome patients can be mimicked by the reduction of wild-type (WT) COPA protein levels.